HOME >> MEDICINE >> NEWS
Designing an ultrasensitive 'optical nose' for chemicals

A laser-based method for identifying a single atom or molecule hidden among 10 trillion others soon may find its way from the laboratory to the real world.

Developed by physicists at the National Institute of Standards and Technology (NIST), the technique is believed to be more than 1,000 times more sensitive than conventional methods. Vescent Photonics of Denver, Colo., hopes to commercialize the method as an "optical nose" for atmospheric monitoring. The portable sensors would rapidly identify chemicals in a gas sample based on the frequencies of light they absorb. Other applications eventually may include detection of chemical weapons and land mines, patient breath analysis for medical diagnosis or monitoring, and industrial detection of leaks in subterranean pipes or storage tanks, the company says.

Vescent recently signed a Cooperative Research and Development Agreement with NIST. The company will work with NIST physicist Jun Ye (co-developer of the technology) to apply the public domain "optical nose" technique to detecting and quantifying trace quantities of atmospheric gases. Ye works at JILA, a joint institute of NIST and the University of Colorado at Boulder.

The technique is a product of years of work and several innovations by NIST scientists. A gas sample is placed in an optical cavity containing two highly reflective mirrors. An infrared laser beam is directed into the cavity, where the light bounces back and forth many times. The repeated reflections increase the path length on which laser light will interact with gas molecules in the sample. In addition, the laser frequency is quickly and systematically varied in a way that enables scientists to observe and subtract background noise from the signal.

The approach allows analysis of gases that are present in minute concentrations and at very low pressures, which may enable identification of compounds such as explosives that are difficult to detect by other means.
'"/>

Contact: Laura Ost
laura.ost@nist.gov
301-975-4034
National Institute of Standards and Technology (NIST)
10-Nov-2004


Page: 1 2

Related medicine news :

1. Views Of Tamoxifen And Synthetic Estrogen In Action Provide Clues For Designing Better Drugs
2. Protecting children from industrial chemicals in the environment
3. Increased suicide rate is possibly linked to chemicals released from nearby asphalt plants
4. Nicotine more addictive when combined with other tobacco smoke chemicals, UCI study finds
5. University of Pittsburgh studies broccoli-derived chemicals to prevent prostate cancer
6. Fetal exposure to two chemicals cause of male reproductive disorders later in life
7. Preventing stray chemicals in food, pharmaceutical and industrial products
8. Organically grown foods higher in cancer-fighting chemicals than conventionally grown foods
9. Brain chemicals can thwart desire to smoke cigarettes
10. Chemical engineers suggest Alzheimers onset tied To cholesterol, brain chemicals

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Designing ultrasensitive optical nose for chemicals

(Date:6/19/2013)... As warmer weather arrives and vacations begin, Asheville’s ... summertime packages. , “Whether guests are traveling to Asheville ... staycation, we think that these available packages will offer ... so beautiful in the summertime and there is a ... can choose from, based on their interests, offers something ...
(Date:6/19/2013)... 2013 According to Fastcare ... sun exposure is perhaps the biggest and certainly ... that is just one of many potential factors ... cancer. Other risk factors include:, , ... ,     Heredity may play a role , ...
(Date:6/19/2013)... The benefits, NASS said, ... the overall experience for the majority of those who ... Mr Mouw, whose Virgina-based company enjoys an international clientele, ... saying that the type of sauna is also important. ... counterfeit imitations which frankly, can be extremely dangerous particularly ...
(Date:6/19/2013)... Hollywood, CA (PRWEB) June 19, 2013 ... conditions with little to no access to the medical ... organizations are providing access to health care and the ... of these third-world nations. , Outlook with ... organizations to reveal the conditions in which these people ...
(Date:6/19/2013)... 19, 2013 Daily Gossip issued a press ... method will be published on their website at the ... article to inform readers about the information they will find ... reporters working at Daily Gossip, the article is a review ... , Hiller has understood during the vast research he has ...
Breaking Medicine News(10 mins):Health News:Fun Depot Partners with Brookstone Lodge on Summer Packages 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 2Health News:Risk Factors of Skin Cancer & Reducing That Risk 3Health News:Health Benefits of Saunas Only Viable with Properly Constructed Models, Warns Manufacturer 2Health News:The Jump Manual Review: Reveals Hiller’s Method of Vertical Jump Training 2
(Date:6/19/2013)... Calif. , June 19, 2013 Pharmacyclics, ... announced that The New England Journal of Medicine ... 2 study evaluating the investigational oral Bruton,s tyrosine kinase ... lymphoma (MCL) online. These data suggested ibrutinib may be ... Results of a separate study examining ...
(Date:6/19/2013)...  Haemonetics Corporation (NYSE: HAE ) ... of its previously announced manufacturing transformation.  ... , Haemonetics has selected Sanmina Corporation (NASDAQ: ... medical devices currently manufactured in Braintree ... of integrated manufacturing solutions, components, products and repair, ...
(Date:6/19/2013)... YORK , June 19, 2013 /PRNewswire-iReach/ -- ... pioneer of modern hair transplant procedures and founder ... was included in the ,Best Doctors, issue of ... (Photo:  http://photos.prnewswire.com/prnh/20130619/CG34629 ) ... Best Doctors issue, and his reputation as world-renowned ...
Breaking Medicine Technology:Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 2Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 3Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 4Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 5Ibrutinib Phase 2 Study Results in Patients with Mantle Cell Lymphoma Published in The New England Journal of Medicine 6Haemonetics Announces Next Steps in Manufacturing Transformation 2Haemonetics Announces Next Steps in Manufacturing Transformation 3Haemonetics Announces Next Steps in Manufacturing Transformation 4Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 2Dr. Robert Bernstein in NY Magazine's 'Best Doctors' Issue for 14th Consecutive Year 3
Cached News: